Mesoestetic Mesofiller Intense 1ml

Mesoestetic fillers have a fully biotechnological origin and are compatible with the skin and completely biodegradable.

The mesoestetic laboratory, a specialist for over 30 years present in the field of aesthetic medicine, presents the mesofiller range - the latest generation fillers based on highly cross-linked and highly purified hyaluronic acid for the correction of wrinkles and renewal of facial skin volumetry

Composition

Hyaluronic acid: 25mg/ml
Molecular weight: 2.4 - 4 Mda

Indications

Deep wrinkles
Facial bioplastics
Nose remodeling
Cheekbones
Deep nasolabial folds
Deep marionette lines
Double chin
The jaw area
Depth of Injection: Intradermal; Subcutaneous tissue

The package contains

1 x 1ml pre-filled syringe, 2 x 27G 1/2 needle
Single-use pre-filled syringes. Durability and ease of storage.

Ergonomic piston, 360o range of motion guarantee stability and full control during injection.
Luer-lock protection for maximum safety and comfort of the procedure.
Inverted scale on the syringe.
Uniformity of injection and homogeneity of diffusion guarantee maximum injection accuracy.
Great ease and comfort of injection.
Innovative densiMatrix® technology from mesoestetic®
The process of uniform cross-linking with the BDDE factor allows to obtain a highly cross-linked matrix of hyaluronic acid. 100% cross-linked hyaluronic acid chains = excellent durability and resistance to degradation.

Maximum safety: the primary mission of mesoestetic® is to guarantee the highest quality of manufactured products. The production of mesofiller® fillers is carried out in accordance with the E.P.P.S (Esterilization Permanent Production System) procedure and GMP standards, as well as ISO 13485 and ISO 9001. Mesofiller® fillers are CE0373 certified, in accordance with the European Medical Devices Directive MDD 93/42/EEC.

SEE THE ENTIRE MESOESTETIC BRAND HERE

Contraindications

The mesofiller medical device must not be used:

In periorbital injections (eyelids, eye sockets),
In injections into blood vessels,
For breast augmentation or implantation into bones, tendons, ligaments or muscles.
The mesofiller medical device must not be administered to patients:

With a known tendency to hypertrophic or keloid scars or
with pigmentation disorders,
With previous active autoimmune diseases or undergoing
immunotherapy,
With multiple severe allergies or active inflammations,
With coagulation disorders,
With confirmed hypersensitivity to hyaluronic acid.
The mesofiller medical device cannot be used by pregnant or lactating women
breastfeeding and in persons under the age of eighteen.

MEDICAL WARNING

The mesofiller medical device may only be used for subcutaneous or subcutaneous injections
intradermal and must not be injected intravascularly. During the procedure
there is a potential risk of accidentally injecting the material into blood vessels.
In rare cases, there may be vascular occlusion, abscess, necrosis or phenomenon
embolic. In order to verify that during normal use of the medical device
needle is not in a blood vessel, it must be inserted before proceeding with the injection
gently aspirate with a syringe.
The mesofiller medical device is packaged for use in one patient only
within the same session.
The mesofiller medical device is supplied sterile and disposable and must not be used
re-sterilize. Do not reuse.
Use the mesofiller medical device immediately after opening the blister and dispose of it
syringe immediately after use, even if not all of it has been used.
Do not use the product after the expiration date stated on the package.
Do not use the mesofiller medical device with other injectable products and not
mix it with other preparations before use.
Do not use the mesofiller medical device if there are areas of redness, swelling or pigmentation changes on the skin. Do not use the mesofiller medical device in case of inflammation, infection or fever.
In patients taking medicines that slow blood clotting (such as aspirin) they may
petechiae or obvious bleeding around the injection site. patients
treated with anticoagulants should, after consultation with their physician, refrain from them
taken for at least 14 days before receiving injections of the medical device
mesofiller.
Keep the product out of the reach of children.

Check out the entire Venome brand offering HERE

The products are intended for professional use.